PREVIOUS QUESTION:

 

NEXT QUESTION:

 

Can a clinical trial help treat non-small-cell lung cancer?

ANSWER

Scientists are looking for new ways to fight lung cancer. A clinical trial may be a good option if what you’re doing isn’t working, especially if you have stage IV cancer. Ask your doctor about any clinical trials for ALK-positive lung cancer. Clinicaltrials.gov is another good place to try. Try typing "ALK-positive lung cancer" in the search box.

Remember, you’re at the heart of your health care team. Taking a proactive approach to care and treatment can help you feel more in control. Deciding on the right treatment for cancer is a personal choice. It’s OK to ask questions if you’re not sure how a medicine or therapy might affect you, and to tell your doctor how you’re really doing -- physically and emotionally. It’s normal to have strong feelings when you’re dealing with cancer. Your doctor can put you in touch with a counselor and support group so you can talk to people who understand what you’re going through.

SOURCES:

Roswell Park Cancer Institute: "Targeting Anaplastic Lymphoma Kinase (ALK) Gene in Non-Small Cell Lung Cancer."

My Cancer Genome: "ALK in Non-Small Cell Lung Cancer (NSCLC)."

Genetics Home Reference: "ALK."

Lung Cancer Foundation of America: "What Targeted Therapies Are Currently Available?"

Memorial Sloan Kettering Cancer Center: "Genomic Testing."

UpToDate: Anaplastic lymphoma kinase (ALK) fusion oncogene positive non-small cell lung cancer.”

American Cancer Society: "Treatment choices by stage for non-small cell lung cancer."

American Cancer Society: "Targeted therapies for non-small cell lung cancer."

Bang, Y.J. October 2012. Archives of Pathology & Laboratory Medicine,

Korpanty, G.J. , 2014. Frontiers in Oncology

UpToDate: “Patient information: Non-small cell lung cancer treatment; stage IV cancer (Beyond the Basics)."

Lab Tests Online. "ALK Mutation (Gene Rearrangement)." 

American Cancer Society: “Cancer Facts & Figures 2015.”

American Cancer Society: “Lung Cancer (Non-Small Cell).”

Reviewed by Laura J. Martin on June 06, 2018

SOURCES:

Roswell Park Cancer Institute: "Targeting Anaplastic Lymphoma Kinase (ALK) Gene in Non-Small Cell Lung Cancer."

My Cancer Genome: "ALK in Non-Small Cell Lung Cancer (NSCLC)."

Genetics Home Reference: "ALK."

Lung Cancer Foundation of America: "What Targeted Therapies Are Currently Available?"

Memorial Sloan Kettering Cancer Center: "Genomic Testing."

UpToDate: Anaplastic lymphoma kinase (ALK) fusion oncogene positive non-small cell lung cancer.”

American Cancer Society: "Treatment choices by stage for non-small cell lung cancer."

American Cancer Society: "Targeted therapies for non-small cell lung cancer."

Bang, Y.J. October 2012. Archives of Pathology & Laboratory Medicine,

Korpanty, G.J. , 2014. Frontiers in Oncology

UpToDate: “Patient information: Non-small cell lung cancer treatment; stage IV cancer (Beyond the Basics)."

Lab Tests Online. "ALK Mutation (Gene Rearrangement)." 

American Cancer Society: “Cancer Facts & Figures 2015.”

American Cancer Society: “Lung Cancer (Non-Small Cell).”

Reviewed by Laura J. Martin on June 06, 2018

NEXT QUESTION:

What is the most common type of lung cancer?

WAS THIS ANSWER HELPFUL

THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for general informational purposes only and does not address individual circumstances. It is not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911.

    This tool does not provide medical advice. See additional information.

    Other Answers On: